CAY10746
CAY10746 is a selective Rho kinase (ROCK) inhibitor, targeting ROCK I and ROCK II with IC50 values of 0.014 μM and 0.003 μM, respectively. CAY10746 can be employed in the study of diabetic retinopathy.
Product Specifications
CAS Number
2247240-76-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
457.48
Molecular Formula
C26H23N3O5
Notes
Research use only, not for human use.
Receptor
ROCK
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C8050-05 100 µg
KCNIP3, aa1-256, Recombinant, Human (Calsenilin, A-type Potassium Channel Modulatory Protein 3, DRE-antagonist Modulator, DREAM, Kv Channel-interacting Protein 3, KChIP3, CSEN, DREAM)
Ask
View Details 